A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech

Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027. 

Physician compensation is rising faster in cardiology than any other specialty. Still, considering how demanding the job is, many cardiologists feel underpaid.

Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.

Medicare may have paid up to $105 million for questionable vascular procedures in 2023 alone, according to a new OIG report. No accusations have been made at this time, but the government thinks 139 different physicians deserve "further scrutiny."

A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context. 

The company keeps gaining momentum thanks to the success of its AI-powered imaging software. 

These programs may provide benefits in some cases. In others, however, there is a concern that they could actually lead to higher costs over time.

When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.